Global Renal Dialysis Equipment Market Products and End-Use Applications Report 2019: Hemodialysis Products Dominate Over 80% of the Market - Projections to 2024

| Source: Research and Markets Research and Markets

Dublin, Feb. 20, 2019 (GLOBE NEWSWIRE) -- The "Global Renal Dialysis Equipment Market - Products and End-Use Applications" report has been added to ResearchAndMarkets.com's offering.

Hemodialysis products dominate over 80% of the market, whereas the peritoneal dialysis products market is growing robustly with a compound annual growth rate of 7.8% during the forecast period. Increasing rate of prevalence of terminal kidney failure patients drives the hemodialysis equipment segment. North America is the world's largest market for Renal Dialysis Equipment, estimated at US$5.3 billion (31% share) in 2018, which is projected to reach US$7 billion by 2024.

Research Findings &Coverage

  • Global Renal Dialysis Equipment market is analyzed in this report with respect to key product types and major end-use applications
  • The study exclusively analyzes the market of each product type and application of Renal Dialysis Equipment by major geographic region/country
  • The market size of Renal Dialysis Equipment is estimated for the product types and applications across all major countries
  • Genetic variation analysis identify new targets for chronic kidney disease treatment
  • Older patients on dialysis have a high risk of dementia
  • Role of hormone replacement therapy in kidney dialysis patients
  • Hemodialysis blood accessibility made easy by new magnetic technology
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 20
  • The industry guide includes the contact details for 70 companies

Analysis Period, Units and Growth Rates

  • The report reviews, analyzes and projects the global renal dialysis equipment market for the period 2015-2024 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2024.

Key Topics Covered:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 Kidney and its Function
1.1.2 Renal Failure
1.1.2.1 Acute Kidney Injury
1.1.2.1.1 Signs and Symptoms
1.1.2.1.2 Causes of Acute Kidney Injury
1.1.2.1.3 Diagnosis
1.1.2.1.4 Treatment
1.1.2.2 Chronic Kidney Disease
1.1.2.2.1 Signs and Symptoms
1.1.2.2.2 Causes
1.1.2.2.3 Diagnosis
1.1.2.2.4 Treatment
1.1.2.3 End-Stage Kidney Disease (ESKD)
1.1.2.4 Renal Failure Caused by Diabetes
1.1.2.5 Metabolic Disturbances in Chronic Renal Failure
1.1.2.6 Types of Kidney Failure
1.1.2.7 Treatment of Kidney Failure
1.1.2.7.1 Dialysis
1.1.2.7.2 Kidney Transplant
1.1.3 Renal dialysis
1.1.3.1 Principles of Renal Dialysis
1.1.3.2 Dialysis Accessories
1.1.3.2.1 Dialyzers
1.1.3.2.2 Arteriovenous Fistula (AV Fistula) Needles
1.1.3.2.3 Dialysis Catheters
1.1.3.2.4 Blood Tubing Sets
1.1.3.3 Types of Renal Dialysis
1.1.3.3.1 Hemodialysis
1.1.3.3.1.1 Types of Hemodialysis
1.1.3.3.1.1.1 Conventional Hemodialysis
1.1.3.3.1.1.2 Daily Hemodialysis
1.1.3.3.1.1.3 Nocturnal Hemodialysis
1.1.3.3.1.2 Hemodialysis Equipment
1.1.3.3.1.2.1 Water System
1.1.3.3.1.2.2 Dialyzer
1.1.3.3.1.3 Advantages and Disadvantages of Hemodialysis
1.1.3.3.2 Peritoneal Dialysis
1.1.3.3.2.1 Types of Peritoneal Dialysis
1.1.3.3.2.1.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
1.1.3.3.2.1.2 Automated Peritoneal Dialysis (APD)
1.1.3.3.2.2 Advantages and Disadvantages of Peritoneal Dialysis
1.1.3.3.3 Continuous Renal Replacement Therapy (CRRT)
1.1.3.3.3.1 CRRT Modalities
1.1.3.3.3.1.1 Continuous Venovenous Hemodiafiltration (CVVHDF)
1.1.3.3.3.1.2 Continuous Venovenous Hemofiltration (CVVH)
1.1.3.3.3.1.3 Continuous Venovenous Hemodialysis (CVVHD)
1.1.3.3.3.1.4 Slow, Continuous Ultrafiltration (SCUF)

2. KEY MARKET TRENDS
2.1 Genetic Variation Analysis Identify New Targets for Chronic Kidney Disease Treatment
2.2 Promising Future for Automatic Continuous Renal Replacement Therapy (CRRT) in Dialysis Equipment Market
2.3 Older Patients on Dialysis Have a High Risk of Dementia
2.4 Improving Quality Of Life for Home Dialysis Patients through Remote Patient Management (RPM)
2.5 Role of Hormone Replacement Therapy in Kidney Dialysis Patients
2.6 Innovative Microsensor Enables Kidney Dialysis to be Customized
2.7 New Lipid-Like Dialysis Membrane can Limit the Side Effects of Hemodialysis
2.8 Hemodialysis Blood Accessibility Made Easy by New Magnetic Technology
2.9 Roxadustat, a New Treatment Option for the Anemia of Chronic Kidney Disease
2.10 A Wearable Artificial Kidney: An Alternative to the Conventional Hemodialysis
2.11 New Type of Peritoneal Dialysis Fluid Makes Procedure More Tolerable
2.12 Electronic Percutaneous Anastomosis Technology (EPATH), a Dialysis Catheter System to Improve Outcomes for Hemodialysis Patients
2.13 New Test Foresees Sudden Cardiac Death in Dialysis Patients
2.14 A Wearable Arm Patch Treats Kidney Failure

3. KEY GLOBAL PLAYERS

  • Allmed Group (United Kingdom)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (United States)
  • Bellco S.R.L. (Italy)
  • C. R. Bard Inc. (United States)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Hemoclean Co., Ltd. (South Korea)
  • Medivators, Inc. (United States)
  • Medtronic, Inc. (United States)
  • Nikkiso Co., Ltd. (Japan)
  • Nipro Medical Corp. (United States)
  • Nxstage Medical, Inc. (United States)
  • Teleflex Incorporated (United States)
  • Toray Medical Co. Ltd. (Japan)

4. KEY BUSINESS/PRODUCT TRENDS

  • Fresenius Medical Care Exhibits its Advances in Kidney Care at America Society of Nephrology
  • Baxter to Ink Collaboration Deal with Mayo Clinic to Setup New Center of Excellence for Renal Care
  • B. Braun to Acquire NxStage's Bloodlines Business
  • BD Completes the Acquisition of TVA Medical, Inc for its Dialysis Access Technology
  • Fresenius Medical Care to Sign Strategic Partnership Agreement with Humacyte
  • B. Braun Acquires Five Renal Care Centers of Diaverum in Australia and New Zealand
  • Baxter to Collaborate with the International Society of Nephrology to Advance CKD Awareness
  • Fresenius Kidney Care Achieved Largest Number of CMS Five-Star Quality Ratings
  • CVS Health Plans to Develop a New Home Hemodialysis System
  • Fresenius Medical Care North America Enter into a National Partnership Agreement with National Kidney Foundation
  • Diaverum Acquires Two Clinics Ameneg and Clinese in Brazil
  • Nikkiso to Enhance the Production Capacity in China Fivefold
  • B. Braun Launches a New Website for Dialysis Patients
  • C. R. Bard Receives FDA Premarket Approval for its Lutonix 035 Drug Coated Balloon Catheter
  • B. Braun Receives FDA Approval and Launches New Dialyzer Diacap Pro
  • Fresenius Medical Care Reinforces its Vertically Integrated Dialysis Business by Acquiring NxStage Medical. Inc
  • Nipro Doubles the Production Capacity of Dialysis Filters in China
  • DaVita Unveils a New Alliance Site Network for Early Stage CKD Trials
  • Fresenius Medical Care Launches BicaVera and BicaNova Peritoneal Dialysis Fluids
  • DaVita to Expand its Business by Introducing DaVita Health Solutions
  • B. Braun Collaborated with INTERMEDT Medizin& Technik GmbH to Extend its Dialysis Products
  • Baxter International Unveils Upgraded AK 98 Hemodialysis System for Broader Treatment
  • Fresenius Medical Care Partners with Humana
  • Baxter to Develop a New System to Produce Peritoneal Dialysis Solution
  • Fresenius Collaborates with Cigna to Launch National Value-Based ERSD Program
  • Niproto erect $300 Million Vietnamese plant for Dialysis Equipment
  • Medtronic Receives IDE Approval from FDA to Initiate Study of IN.PACT Admiral Drug-Coated Balloon
  • Fresenius Kidney Care and The Johns Hopkins Hospital Collaborate to Enhance Critical Kidney Care Services
  • DaVita and Inspira Health forms a Dialysis Service Joint Venture in South Jersey
  • Baxter Launches HDx Therapy Enabled by THERANOVA to Offer Improved Hemodialysis Treatments
  • B. Braun Launches xevonta, New Class of Kidney Dialyzer
  • Baxter Partners with Satellite Healthcare to Provide Latest Dialysis Technology
  • Diaverum and Yueda Sign Joint Venture Agreement to Operate Dialysis Clinics in China
  • Fresenius Renal Therapies Launches CLiC Device Next Generation Sentinel Technology
  • Fresenius Medical Care Launches 6008, a New Hemodialysis Therapy System in the Asia-Pacific Market
  • Nikkiso Launches DBB-06 Hemodialysis System in the U.S. Market
  • Fresenius Medical Care Acquires 85 Percent Stake in Sandor Nephro Services
  • Medtronic Acquires Bellco as Part of Newly Formed Renal Care Solutions Business

5. GLOBAL MARKET OVERVIEW
5.1 Global Renal Dialysis Equipment Market Overview by Product Type
5.1.1 Global Renal Dialysis Equipment Product Type Market Overview by Geographic Region
5.1.1.1 Hemodialysis
5.1.1.2 Peritoneal Dialysis
5.2 Global Renal Dialysis Equipment Market Overview by End-Use Application
5.2.1 Global Renal Dialysis Equipment Application Market Overview by Geographic Region
5.2.1.1 Medical Center Dialysis
5.2.1.2 In-Home Dialysis

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

Major Market Players

  • Baxter International, Inc. (United States)
  • C. R. Bard Inc. (United States)
  • Davita Inc. (United States)
  • Medivators, Inc. (United States)
  • Medtronic, Inc. (United States)
  • Nipro Medical Corp. (United States)
  • Nxstage Medical, Inc. (United States)
  • Rockwell Medical, Inc. (United States)
  • Teleflex Incorporated (United States)

7. EUROPE

Major Market Players

  • Allmed Group (United Kingdom)
  • B. Braun Melsungen AG (Germany)
  • Bellco S.R.L. (Italy)
  • Dialife SA (Switzerland)
  • Diaverum (Sweden)
  • Fresenius Medical Care Ag & Co. KGaA (Germany)

8. ASIA-PACIFIC

Major Market Players

  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Hemoclean Co., Ltd. (South Korea)
  • Nikkiso Co., Ltd. (Japan)
  • Terumo Corporation (Japan)
  • Toray Medical Co. Ltd. (Japan)

9. SOUTH AMERICA

10. REST OF WORLD

PART C: GUIDE TO THE INDUSTRY

PART D: ANNEXURE

Companies Mentioned

  • Allmed Group
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • BD
  • Baxter International, Inc.
  • Bellco S.R.L.
  • C. R. Bard Inc.
  • CVS Health
  • Cigna
  • Davita Inc.
  • Dialife SA
  • Diaverum
  • Fresenius Medical Care AG & Co. KGaA
  • Hemoclean Co., Ltd.
  • Humacyte
  • INTERMEDT Medizin & Technik GmbH
  • Inspira Health
  • Johns Hopkins Hospital
  • Medivators, Inc.
  • Medtronic, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Medical Corp.
  • Nxstage Medical, Inc.
  • Rockwell Medical, Inc.
  • TVA Medical, Inc
  • Teleflex Incorporated
  • Terumo Corporation
  • Toray Medical Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/v84n79/global_renal?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. 


            











    

        

        
Contact Data